Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.

It’s clear there’s a strong connection between sustained earnings growth and hall-of-fame returns. Keeping that in mind, here are three market-beating stocks that deserve a spot on your list.

KLA Corporation (KLAC)

Five-Year Return: +393%

Formed by the 1997 merger of the two leading semiconductor yield management companies, KLA Corporation (NASDAQ: KLAC) is the leading supplier of equipment used to measure and inspect semiconductor chips.

Why Will KLAC Beat the Market?

1. Market share has increased this cycle as its 16.1% annual revenue growth over the last five years was exceptional
2. Superior product capabilities and pricing power lead to a best-in-class gross margin of 60.6%
3. Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends

At $1,550 per share, KLA Corporation trades at 38.4x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

United Therapeutics (UTHR)

Five-Year Return: +172%

Founded by a mother seeking treatment for her daughter's pulmonary arterial hypertension, United Therapeutics (NASDAQ: UTHR) develops and commercializes medications for chronic lung diseases and other life-threatening conditions, with a focus on pulmonary hypertension treatments.

Why Should You Buy UTHR?

1. Annual revenue growth of 19.1% over the last two years was superb and indicates its market share increased during this cycle
2. Strong free cash flow margin of 34.9% enables it to reinvest or return capital consistently, and its recently improved profitability means it has even more resources to invest or distribute
3. Returns on capital are climbing as management makes more lucrative bets

United Therapeutics is trading at $467.53 per share, or 16.1x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.

Synchrony Financial (SYF)

Five-Year Return: +96.2%

Powering over 73 million active accounts and partnerships with major brands like Amazon, PayPal, and Lowe's, Synchrony Financial (NYSE: SYF) provides credit cards, installment loans, and banking products through partnerships with retailers, healthcare providers, and digital platforms.

Why Do We Love SYF?

1. Share buybacks catapulted its annual earnings per share growth to 30.1%, which outperformed its revenue gains over the last two years
2. Balance sheet strength has increased this cycle as its 20.8% annual tangible book value per share growth over the last two years was exceptional
3. Market-beating return on equity illustrates that management has a knack for investing in profitable ventures

Synchrony Financial’s stock price of $77.88 implies a valuation ratio of 8.5x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.